Metabolic Syndrome and Outcome Predictions: Friends or Foes?

Area of Science:

• Cardiovascular Epidemiology
• Clinical Risk Prediction
• Metabolic Disorders

Background:

• Metabolic Syndrome (MS) is a cluster of risk factors, but its utility in predicting cardiovascular disease (CVD) events remains debated.
• The International Diabetes Federation (IDF) provides specific criteria for MS classification.
• Traditional risk factor assessment is a cornerstone of cardiovascular disease (CVD) risk prediction.

Purpose of the Study:

• To evaluate whether the Metabolic Syndrome (MS) classification improves the prediction of coronary heart disease (CHD) and major cardiovascular disease (CVD) fatal events.
• To compare the predictive performance of MS criteria against traditional risk factor assessment methods.

Main Methods:

• Analysis of epidemiological data from the Italian Risk Factors and Life Expectancy (RIFLE) study (over 25,000 men).
• Cox proportional hazard models were used to predict CHD and CVD fatal events over a seven-year follow-up.
• Models were compared using Akaike Information Criterion (AIC), with and without serum cholesterol as a covariate.

Main Results:

• Models using individual risk factor measurements significantly outperformed the IDF-MS classification.
• A model incorporating serum cholesterol provided significantly better prediction of CHD events compared to models without it.
• Factor analysis-derived scores showed intermediate predictive performance.

Conclusions:

• The IDF-MS classification offers no additional predictive value for cardiovascular events beyond traditional risk factor analysis.
• Excluding serum cholesterol from cardiovascular risk prediction models is an error.
• Serum cholesterol is a crucial predictor for the coronary heart disease (CHD) component of major cardiovascular disease (CVD) events.